Skip to main content

Increasing Prevalence of Chronic Disorders and Approval and Launch of New Products to Augment Growth of Medical Membrane Market

 


Advancements in medical sciences, rising incidences of fatal diseases, improvement in medical technology, growth in pharmaceutical and medical industry, increased demand for safe medicines and pharmaceutical products are some of the major driving forces that are expected to drive the medical membrane industry for hematological application and other pharmaceutical purification process.

Medical membranes, which help to safeguard different biological resources are extremely important as they help in protecting our health from various deadly and contagious diseases. These applications include the manufacturing of customized biocompatible solutions for the protection and purification of biological fluids. This industry is witnessing an exponential growth with constant inflow of pharmaceutical products, research and development activities. As per the statistics, there has been a steady rise in the demand for medical devices, materials and equipment that are required for the purification of medicines. With the right purification procedure, the drugs present in the body can remain active and the harmful chemicals out of the system can be avoided.

Market Dynamics

Increasing prevalence of chronic disorders is expected to propel growth of the global medical membrane market. For instance, according to the study, ‘Risk Factors and Rate of Progression of CKD in Children’, published in June 2019 in Kidney International Reports, 38% children experienced progression of chronic kidney disease within 2 years of follow-up.

The global medical membrane market is witnessing several M&A activities. For instance, in December 2020, Collagen Matrix, Inc., a regenerative, collagen-based, xenograft-derived medical devices provider, acquired Sunstar's Degradable Solutions division including its GUIDOR branded line of resorbable synthetic medical implants. Similarly, in January 2021, Blue Earth Diagnostics, a Bracco company, signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in radiopharmaceuticals and radiopharmaceutical technologies, and the Technical University of Munich, to acquire exclusive, worldwide rights to therapeutic applications of novel radiohybrid Prostate-Specific Membrane Antigen technology in prostate cancer.

Among regions, North America is expected to witness significant growth in the global medical membrane market, owing to high prevalence of cancer in the region. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Competitive Analysis

Major players operating in the global medical membrane market include, Nipro Corporation, Amniox, Pall Corporation, Sorin Group, Gore, OXGENE, Maquet Company, Merck Millipore, and others.

Major players operating in the global medical membrane market are focused on approval and launch of new products to expand their product portfolio. For instance, in January 2021, OXGENE, a biotechnology company offering integrated discovery and manufacturing technologies to the cell and gene therapy industry, launched its self-labelling integral membrane (SLIM) protein discovery system.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...
Post a Comment
Read more

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 
Post a Comment
Read more

Custom Antibody Service Market Segmentation Application, Technology and Market Analysis to 2028

  The immune system produces antibodies in response to pathogen invasion. Antigens are the collective term for the invasive bacteria, viruses, or other foreign molecules. Antibodies are proteins, or polypeptides which have specific antigen recognition sites. It is possible to have antibodies made using custom antibody production when an antibody is required against a particular antigen but it is not offered by a supplier. These antibodies can be either polyclonal or monoclonal, depending on how they are produced and harvested. Polyclonal  antibodies  are capable of recognizing multiple sites on an antigen. They are derived from different B-cell lineages. Monoclonal antibodies recognize only one epitope or site on an antigen, and are derived from a single B-cell line. Global custom antibody service market is estimated to be valued at  US$ 444.85 Million in 2022  and expected to reach  US$ 930.46 million by 2030 , witnessing a  CAGR of 9.7 %  over...
Post a Comment
Read more